The global Paclitaxel and Its Analogue in Anticarcinoma Drugs market size was valued at US$ 4.87 billion in 2024 and is projected to reach US$ 6.91 billion by 2030, at a CAGR of 6.0% during the forecast period 2024-2030. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs market size was valued at US$ 1.96 billion in 2024 and is projected to US$ 2.73 billion by 2030, at a CAGR of 5...
